---
$id: https://graph.org.ai/products/commodity/51111740
$type: Product
source: UNSPSC
code: "51111740"
title: "Daunorubicin hydrochloride"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Daunorubicin hydrochloride

**UNSPSC Code**: 51111740
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthracycline antibiotic with the molecular formula C27H29NO10.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UD984I04LZ, chemically known as 5,12-naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, radical ion(1-), (8s,10s)- but generally known as daunorubicin hydrochloride, which bears US NIH Compound Identifier 2958. European Medicines Agency schedules Daunorubicin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01556MIG. Most nations schedule daunorubicin hydrochloride under HS 29419000 and SITC 54139. As of Q4 2014, DAUNORUBICIN HYDROCHLORIDE remains the US FDA Preferred Term for this commodity. Daunorubicin hydrochloride bears US NLM identifiers UMLS ID C0701062 and NCI Concept Code C1583. SMILES: O(C1CC(O)(Cc2c1c(O)c1c(c2O)C(=O)c2c(C1=O)c(OC)ccc2)C(=O)C)C1OC(C(O)C(N)C1)C.

